How Merck Is Trying to Keep Disrupters at Bay
Harvard Business Review
JUNE 8, 2015
With its Emerging Businesses (EB) group (where one of us serves as President), Merck started a journey about three years ago with a core investment thesis: there are areas of growing unmet need in health care that intersect with its established competencies. Experimentation is vital.
8 
Let's personalize your content